NAME LEN 150 MG/G ORAL DROPS SUSPENSION FOR CATS DOGS UP TO 10 KG CATS AND DOGS (PUPPIES) ACTIVE INGREDIENTS 1 g of suspension contains the active substance: mebendazole 150 mg. Excipients: white petrolatum, olive oil. THERAPEUTIC INDICATIONS Anthelmintic for the treatment of parasitic infestations caused by Toxocara canis, Toxascaris leonina, Toxocara cati, Trichuris vulpis, Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala, Dipylidium caninum, Taenia spp. CONTRAINDICATIONS / ADVERSE EFFECTS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. SAFETY IN TARGET SPECIES Administration of excessive doses causes vomiting at doses above 500 mg/kg of active ingredient in dogs and above 300 mg/kg of active ingredient in cats. DOSAGE Oral administration. One drop of suspension contains 5 mg of mebendazole: administer 4 drops/kg body weight/day (equivalent to 20 mg/kg body weight/day of active ingredient) for ascaris infestations, even if mixed, and 8 drops/kg body weight/day (equivalent to 40 mg/kg body weight/day of active ingredient) for tapeworm and tapeworm plus ascaris infestations. In both cases, the indicated dose should be administered for 3 consecutive days. Always round the animals weight to the next whole number. The veterinary medicinal product can also be administered to puppies in the first weeks of life. Administer the drops directly into the mouth or mixed with palatable food. Shake vigorously before use until the sediment is completely dispersed. During treatment, the animal does not lose either its activity or appetite. The product is well tolerated even by very weak animals and those with intercurrent diseases. STORAGE: Keep the bottle in the original packaging in order to protect from light. Shelf life of the veterinary medicinal product as packaged for sale: 5 years. Shelf life after first opening the immediate packaging: 6 months. WARNINGS: In order to achieve effective parasite control, treatment should be based on the results of a parasitological examination of the faeces. Parasitic resistance to a particular class of anthelmintics may develop following frequent and repeated use of an anthelmintic of the same class. Special precautions for safe use in the target species: It is good practice, during deworming, to feed animals lighter meals than usual. It is preferable to administer the product on an empty stomach. Administration of the veterinary medicinal product according to the indicated methods results in the disappearance of adult parasites; To eliminate larval forms of hookworms and roundworms, the complete treatment should be repeated 60 days after the first treatment for roundworm infestations and 18 days after the first treatment for hookworm infestations. Elimination of parasites begins with the first administration and eggs usually disappear within approximately ten days of the last administration. Therefore, a faecal examination should be performed after this period. During and after treatment, appropriate disinfection procedures should be carried out, particularly in kennels or breeding units, to prevent reinfestation. In addition, it is recommended to chemically denature the faeces expelled by treated subjects in order to destroy any live parasites eliminated and thus interrupt the continuation of the parasitic cycle. Special precautions to be taken by the person administering the veterinary medicinal product to animals: People with known hypersensitivity to mebendazole should administer the veterinary medicinal product with caution. Special precautions for environmental protection: Not applicable. Special restrictions on use and special conditions of use, including restrictions on the use of antimicrobials and antiparasitic veterinary medicinal products to limit the risk of development of resistance: Not applicable. Administration of excessive doses causes vomiting above 500 mg/kg body weight of active ingredient in dogs and above 300 mg/kg body weight of active ingredient in cats. In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other medicinal products. TARGET SPECIES: Cats and dogs. INTERACTIONS: None known. ADVERSE REACTIONS: Cats and dogs. Very rare (< 1 animal/10,000 animals treated, including isolated reports): vomiting and diarrhoea*, hepatotoxic reactions. * mild and transient gastrointestinal disturbances. Reporting of adverse events is important as it allows continuous monitoring of the safety of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, the marketing authorisation holder or the national competent authority via the national reporting system. See package leaflet for contact details. PREGNANCY AND LACTATION: Not recommended for use during the first fifteen days of pregnancy. Can be used during lactation